Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B UncertaintyBenzinga • 02/11/25
Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025PRNewsWire • 02/06/25
Wall Street Analysts Believe Dynavax Technologies (DVAX) Could Rally 93.2%: Here's is How to TradeZacks Investment Research • 01/29/25
Dynavax Technologies (DVAX) Upgraded to Buy: Here's What You Should KnowZacks Investment Research • 01/16/25
Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial HighlightsPRNewsWire • 01/13/25
Does Dynavax Technologies (DVAX) Have the Potential to Rally 93.52% as Wall Street Analysts Expect?Zacks Investment Research • 11/27/24
Wall Street Analysts Predict an 88.32% Upside in Dynavax Technologies (DVAX): Here's What You Should KnowZacks Investment Research • 11/11/24
Dynavax Reports Third Quarter 2024 Financial Results and Provides Business UpdatesPRNewsWire • 11/07/24
Glancy Prongay & Murray LLP Announces Investigation of Dynavax Technologies Corporation (DVAX)Business Wire • 11/06/24
Dynavax to Report Third Quarter 2024 Financial Results and Host Conference Call on November 7, 2024PRNewsWire • 10/24/24
How Much Upside is Left in Dynavax Technologies (DVAX)? Wall Street Analysts Think 135.98%Zacks Investment Research • 08/09/24
Dynavax Reports Second Quarter 2024 Financial Results and Provides Business UpdatesPRNewsWire • 08/06/24
Dynavax to Report Second Quarter 2024 Financial Results and Host Conference Call on August 6, 2024PRNewsWire • 07/23/24